Loading data for ENVB — first visit, this takes a few seconds.
Enveric Biosciences, Inc.
1.48 +0.04 (2.78%)
1.38 -2.52%
- Market Cap
- $6.36M
- Volume
- 104K
- Dividend yield
- n/a
Enveric Biosciences, Inc. (ENVB) Stock Price, Analysis & Data
Intrinsic Value
Analyst Forecast
Stock Forecasts →Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | $0 | n/a | n/a |
| EPS | -$2,03 | +$0,73 | +98.94% |
Metrics
- Bid
- 1.08
- Market Cap
- 6.36M
- Revenue (ttm)
- n/a
- Net Income (ttm)
- -12.1M
- 1.11
- -12.18
- n/a
- -1.01
- P/B (ttm)
- 0.69
- P/S (ttm)
- n/a
- Earnings Date
- n/a
- Ask
- 1.81
- Volume
- 104,183
- Avg. Volume (20D)
- 120,341
- Open
- 1.48
- Previous Close
- 1.44
- Day's Range
- 1.41 - 1.54
- 52-Week Range
- 1.17 - 13.25
- Analyst
- n/a
- Price Target
- n/a
- Dividends
- n/a
- Ex-Dividend Date
- Apr 23, 2008
About Enveric Biosciences, Inc.
View profile →Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Industry Biotechnology
Sector Healthcare
IPO Date May 4, 2015
Employees 5
Stock Exchange NasdaqCM
Ticker Symbol ENVB
Website https://www.enveric.com